Umbilical cord tissue-derived product(Arugula)

N/A

Report date: 2025/03/25 16:31:35

Base Information

Drug NameUmbilical cord tissue-derived product(Arugula)
Drug Alias NameSignature Cord Prime™SIG001(Arugula)SIG-001(Arugula)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSignature Biologics LLCKlm Solutions LLCArugula Sciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesArugula Sciences LLC
Inactive CompaniesKlm Solutions LLCSignature Biologics LLC
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A